Prescribed drugs and neurological complications

Neurology in Practice

Volumn 75, Issue 3, 2004, Pages

  Grosset, K A ^a   Grosset, D G ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOGLYCOSIDE; AMIODARONE; AMPHETAMINE; ANALGESIC AGENT; ANDROGEN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CARDIAC GLYCOSIDE; CONTRACEPTIVE AGENT; CYTARABINE; DESOGESTREL; ESTROGEN; FLUOROURACIL; GESTODENE; LEVONORGESTREL; LITHIUM; NEUROLEPTIC AGENT; OPIATE; PHENYTOIN; PIPERAZINE; PROGESTERONE; PROTON PUMP INHIBITOR; SEDATIVE AGENT; UNINDEXED DRUG; VASODILATOR AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CERIVASTATIN; CHLORAMPHENICOL; CHLORPROMAZINE; DOPAMINE; FLUINDOSTATIN; GEMFIBROZIL; ISOTRETINOIN; PENICILLAMINE; PRAVASTATIN; RETINOID; SIMVASTATIN; TUBERCULOSTATIC AGENT; VACCINE; VINCA ALKALOID;

AGITATION; AKATHISIA; BEHAVIOR; BLOOD PRESSURE; CEREBELLUM ATROPHY; CHOREA; CONFUSION; DEMYELINATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; GLYCEMIC INDEX; GUILLAIN BARRE SYNDROME; HEADACHE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; IMMUNIZATION; INFECTION RISK; LEUKOPENIA; MOTOR DYSFUNCTION; MULTIPLE ORGAN FAILURE; MYOPATHY; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGICAL COMPLICATION; NEUROMUSCULAR BLOCKING; NEUROTOXICITY; OPTIC NERVE DISEASE; PARKINSONISM; PERIPHERAL NEUROPATHY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SEIZURE; STROKE; TARDIVE DYSKINESIA; THROMBOCYTOPENIA; TREMOR; VEIN THROMBOSIS; ATAXIA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DEMYELINATING DISEASE; DRUG BLOOD LEVEL; DRUG USE; DYSARTHRIA; EYE TOXICITY; LEUKEMIA; LYMPHOMA; MUSCULOSKELETAL DISEASE; MYASTHENIA; NEUROLOGIC DISEASE; NYSTAGMUS; PSORIASIS; RETROBULBAR OPTIC NEUROPATHY; RISK ASSESSMENT; SIDE EFFECT; SOLID TUMOR; VENOUS THROMBOEMBOLISM;

CEREBELLAR DISEASES; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DRUG INTERACTIONS; HEADACHE; HUMANS; NEUROMUSCULAR DISEASES; OPTIC NEURITIS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG; SEIZURES;

EID: 4344683289     PISSN: 14737086     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.045757     Document Type: Review

References (10)

1. Verstappen CC, Heimans JJ, Hoekman K, et al. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003;63:1549-63. Detailed neurological review of central and peripheral effects.
2. Ener RA, Meglathery SB, Van Decker WA, et al. Serotonin syndrome and other serotonergic disorders. Pain Med 2003;4:63-74. Comprehensive up-to-date review including pathophysiology and treatment.
3. Toth C. Medications and substances as a cause of headache: a systematic review of the literature. Clin Neuropharmacol 2003;26:122-36. Current concepts of medication induced and medication overuse headache.
4. Griffin JP. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug React Toxicol Rev 1992;11:41-57. Covers diagnosis and treatment and tabulates prior papers associated with prescription medication according to drug or disease area.
5. Rodnitzky RL. Drug-induced movement disorders. Clin Neurophormacol 2002;25:142-52. Separate coverage of acute and chronic reactions; logical review of dystonia, akathisia, chorea, parkinsonism, and available treatment strategies.
6. Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs 2002;16:23-45. Covers development, neuropharmacology, and individually the acute and tardive complications for each of the atypical neuroleptics.
7. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv 1998;49:1163-72. A Medline review, discussion of diagnostic criteria, treatment, retreatment of the primary diagnosis, and biological mechanisms.
8. Visovsky C. Chemotherapy-induced peripheral neuropathy. Cancer Invest 2003;21:439-51. Covers the various categories of cancer drugs associated with neuropathy, including time course.
9. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984;101:92-104. Complications of various antibiotics to the nervous system.
10. Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf 2003;2:233-47. Long article, but worthwhile reading, which makes clear the importance of drug history in patients presenting with collapse/ seizure.